Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

QRG Capital Management Inc. grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.6% in the 3rd quarter, ...

and the Dexcom G6 Continuous Glucose Monitoring (CGM) System. Working together, these components provide an innovative, automated insulin delivery (AID) system designed to simplify insulin therapy ...